Octave Specialty OSG
- Market cap
- $214M
- PE
- n/m
- a loss over the last year
- Forward PE
- n/m
- not a meaningful number
- Price to sales
- n/m
- Q2 FY26 missing
- Revenue, 12 months
- n/m
- Q2 FY26 missing
- Net margin
- n/m
- Q2 FY26 missing
Octave Specialty's trailing earnings are negative, so it has no PE.
Charts
Financials
| Income statement | Q3 FY23 | Q4 FY23 | Q1 FY24 | Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $74M−8% | $75M−66% | $49.6M−15% | $51M−18% | $70M−5% | $65.2M−13% | $62.8M+27% | $55M+8% | $66.6M−5% | $66.9M+3% | $104.2M+66% | n/a | |
| SG&A | $49M+58% | $34M−33% | $17.6M−51% | $27.9M−23% | $44M−10% | $39.7M+17% | $38.5M+119% | $40.5M+46% | $53.7M+22% | $58.8M+48% | $53.2M+38% | n/a |
| Interest expense | $16M−67% | $16M−47% | $0 | $0 | $3.7M−77% | $5.6M−65% | $5.5M | $5.6M | $6.2M+65% | $1.4M−75% | $2.1M−62% | $2.8M−50% |
| Pre-tax income | $68M−80% | −$16M | −$3.2M−89% | −$14.7M+34% | −$20.8M | −$21.1M+32% | −$15.1M+366% | −$23M+56% | −$32.1M+55% | −$30.9M+46% | −$3.3M−78% | n/a |
| $1M−50% | $0 | $130K−97% | −$30K | −$867K | $1.7M | −$617K | −$2.2M+7140% | −$1.2M+43% | $9.2M+447% | −$481K−22% | n/a | |
| Net income | $66M−81% | −$15M | $20.8M | −$750K−94% | −$27.5M | −$547.9M+3553% | −$46.4M | −$72.7M+9593% | −$112.6M+310% | −$27.4M−95% | −$6.9M−85% | −$14.4M−80% |
| $1.41−81% | −$0.24 | $0.44 | −$0.02−93% | −$0.63 | −$11.39+4646% | −$1.21 | −$1.54+7600% | −$2.35+273% | −$0.66−94% | −$0.13−89% | −$0.32−79% | |
| 46.8M+2% | 45.6M−2% | 45.8M+1% | 46.2M+1% | 47.7M+2% | 48.1M+6% | 47.3M+3% | 48.1M+4% | 48.1M+1% | 45.2M−6% | 45.3M−4% | 45.4M−6% |
Net income: Q2 FY26: not printed by the filing, worked out from its own lines.
EPS, diluted: 9 periods, Q4 FY10 to Q2 FY26: quarter's net income to common over its shares, to the cent.
Diluted shares: 9 periods, Q4 FY10 to Q4 FY25: a loss quarter: its basic count, share-days: the 12-month average less the 9-month, weighted by days. Q4 FY12 and Q4 FY22: share-days: the 12-month average less the 9-month, weighted by days.
From each company's 10-Q and 10-K filings, the newest version of each figure. Quarters are as filed (a fourth quarter is the year less its first nine months), fiscal years as the 10-K prints them, restated where a later 10-K restated them, and balance sheet lines as of the period's end. A quarter whose 10-Q isn't filed yet is from the company's results release. Growth is on the same period a year earlier. A dash is a period with no figure for the line: the filing doesn't print it, or it hasn't been read yet.
Peers
Companies in Financial Services nearest Octave Specialty's size, closest first.
| Company | Market cap | PE | Its 10y median PE | Fwd PE | P/S | Revenue growth | Net margin |
|---|---|---|---|---|---|---|---|
| OSGOctave Specialty | $214M | n/m | 7.1× | n/m | n/m | n/m | |
| CPSSConsumer Portfolio Services | $213.4M | 10.8× | 6.0× | 0.5× | +7% | 4.8% | |
| FCAPFirst Capital | $211.9M | 11.5× | 13.0× | n/m | +18% | 33.8% | |
| OPBKOP Bancorp | $219.8M | 7.6× | 8.3× | n/m | +13% | 29.2% | |
| CZWICitizens Community Bancorp | $206.7M | 16.4× | 9.1× | n/m | +10% | 19.9% | |
| MRBKMeridian | $223.3M | 10.2× | 8.4× | n/m | +7% | 16.6% | |
| CFBKCF Bankshares | $223.9M | 11.8× | 8.6× | n/m | +10% | 30.4% | |
| RBKBRhinebeck Bancorp | $202.2M | 14.4× | 10.1× | n/m | +60% | 18.4% | |
| DHXDHI | $201.5M | 155× | 31.4× | 1.6× | −7% | 1.0% | |
| QNBCQNB | $229M | 13.6× | 10.7× | n/m | +25% | 20.3% | |
| LARKLandmark Bancorp | $199.1M | 10.1× | 8.7× | n/m | +14% | 26.9% | |
| Peer median | $212.6M | 11.7× | 8.9× | 1.0× | +11% | 20.1% |
More on Octave Specialty
Each number over time
Its groups
About
- Industry
- Insurance - Specialty
- Sector
- Financial Services
Valuation data, not investment advice. Prices as of .